-
1
-
-
13844275306
-
Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: An SF-36 survey
-
Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology 2005 65 : 290 294
-
(2005)
Urology
, vol.65
, pp. 290-294
-
-
Yoshimura, K.1
Utsunomiya, N.2
Ichioka, K.3
Matsui, Y.4
Terai, A.5
Arai, Y.6
-
2
-
-
36448950859
-
Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: A critical analysis of currently available drugs, treatment schedules, and long-term results
-
Witjes JA, Hendricksen K. Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 2008 53 : 45 52
-
(2008)
Eur Urol
, vol.53
, pp. 45-52
-
-
Witjes, J.A.1
Hendricksen, K.2
-
3
-
-
2142655894
-
NAD(P)H: Quinone oxidoreductase 1: Role as a superoxide scavenger
-
Siegel D, Gustafson DL, Dehn DL et al. NAD(P)H: quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004 65 : 1238 1247
-
(2004)
Mol Pharmacol
, vol.65
, pp. 1238-1247
-
-
Siegel, D.1
Gustafson, D.L.2
Dehn, D.L.3
-
5
-
-
33646129234
-
Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines
-
Watanabe J, Nishiyama H, Matsui Y et al. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. Oncogene 2006 25 : 2500 2508
-
(2006)
Oncogene
, vol.25
, pp. 2500-2508
-
-
Watanabe, J.1
Nishiyama, H.2
Matsui, Y.3
-
6
-
-
2342537109
-
Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY
-
Watanabe J, Nishiyama H, Okubo K et al. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY. Urology 2004 63 : 989 993
-
(2004)
Urology
, vol.63
, pp. 989-993
-
-
Watanabe, J.1
Nishiyama, H.2
Okubo, K.3
-
7
-
-
23044467656
-
Two distinct modes of cell death induced by doxorubicin: Apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype
-
Eom YW, Kim MA, Park SS et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005 24 : 4765 4777
-
(2005)
Oncogene
, vol.24
, pp. 4765-4777
-
-
Eom, Y.W.1
Kim, M.A.2
Park, S.S.3
-
8
-
-
0038482086
-
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
-
Mansouri A, Ridgway LD, Korapati A L et al. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003 278 : 19245 19256
-
(2003)
J Biol Chem
, vol.278
, pp. 19245-19256
-
-
Mansouri, A.1
Ridgway, L.D.2
Korapati, A.L.3
-
9
-
-
0035914266
-
A novel strategy for NQO1 (NAD(P)H: Quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
-
Choudry GA, Stewart PA, Double JA et al. A novel strategy for NQO1 (NAD(P)H: quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9. Br J Cancer 2001 85 : 1137 1146
-
(2001)
Br J Cancer
, vol.85
, pp. 1137-1146
-
-
Choudry, G.A.1
Stewart, P.A.2
Double, J.A.3
-
10
-
-
33748094636
-
Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer
-
Puri R, Palit V, Loadman PM et al. Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer. J Urol 2006 176 : 1344 1348
-
(2006)
J Urol
, vol.176
, pp. 1344-1348
-
-
Puri, R.1
Palit, V.2
Loadman, P.M.3
-
11
-
-
0035969989
-
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
-
Asher G, Lotem J, Cohen B, Sachs L, Shaul Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA 2001 98 : 1188 1193
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 1188-1193
-
-
Asher, G.1
Lotem, J.2
Cohen, B.3
Sachs, L.4
Shaul, Y.5
-
12
-
-
0036594890
-
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
-
Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002 1 : 639 649
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 639-649
-
-
Gartel, A.L.1
Tyner, A.L.2
-
13
-
-
0347628818
-
P21Waf1/Cip1 as a therapeutic target in breast and other cancers
-
Weiss RH. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 2003 4 : 425 429
-
(2003)
Cancer Cell
, vol.4
, pp. 425-429
-
-
Weiss, R.H.1
-
14
-
-
19344367427
-
Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism
-
Bello RI, Gomez-Diaz C, Lopez-Lluch G et al. Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism. Biochem Pharmacol 2005 69 : 1613 1625
-
(2005)
Biochem Pharmacol
, vol.69
, pp. 1613-1625
-
-
Bello, R.I.1
Gomez-Diaz, C.2
Lopez-Lluch, G.3
-
15
-
-
33846014691
-
Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells
-
Du J, Daniels DH, Asbury C et al. Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells. J Biol Chem 2006 281 : 37416 37426
-
(2006)
J Biol Chem
, vol.281
, pp. 37416-37426
-
-
Du, J.1
Daniels, D.H.2
Asbury, C.3
-
16
-
-
49349083531
-
Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling
-
Matsuzawa A, Ichijo H. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 2008 1780 : 1325 1336
-
(2008)
Biochim Biophys Acta
, vol.1780
, pp. 1325-1336
-
-
Matsuzawa, A.1
Ichijo, H.2
-
18
-
-
0031034078
-
Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions
-
Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 1997 89 : 630 643
-
(1997)
Blood
, vol.89
, pp. 630-643
-
-
Zhou, P.1
Qian, L.2
Kozopas, K.M.3
Craig, R.W.4
-
19
-
-
30744473692
-
Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1
-
Derouet M, Thomas L, Moulding DA et al. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol 2006 176 : 957 965
-
(2006)
J Immunol
, vol.176
, pp. 957-965
-
-
Derouet, M.1
Thomas, L.2
Moulding, D.A.3
|